The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial.
Saved in:
| Title: | The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial. |
|---|---|
| Authors: | Liu, Bing1 (AUTHOR), Tao, Ye1 (AUTHOR), Zhuo, Minglei2 (AUTHOR), Xu, Li-Di3 (AUTHOR), Cheng, Xueyan3 (AUTHOR), Tao, Wei3 (AUTHOR), Xie, Zhangdong3 (AUTHOR), Lv, Chao1 (AUTHOR), Wang, Yuzhao1 (AUTHOR), Li, Shaolei1 (AUTHOR), Zhang, Shanyuan1 (AUTHOR), Huang, Miao1 (AUTHOR), Wang, Yaqi1 (AUTHOR), Li, Xiang1 (AUTHOR), Zhu, Yuge1 (AUTHOR), Cui, Xinrui1 (AUTHOR), Zhou, Xuantong1 (AUTHOR), Han, Bateer4 (AUTHOR), Zhang, Enli3 (AUTHOR), Huang, Yu S.3 (AUTHOR) |
| Source: | BMC Medicine. 11/5/2025, Vol. 23 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-025-04419-x |
